Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step.
作者信息
Billard Marie-Noëlle, Bont Louis J
机构信息
Departments of Pediatrics University Medical Center Utrecht Utrecht, the Netherlands.
出版信息
Am J Respir Crit Care Med. 2021 Mar 1;203(5):538-539. doi: 10.1164/rccm.202009-3431ED.
Abstract
摘要
相似文献
1
Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step.
Am J Respir Crit Care Med. 2021 Mar 1;203(5):538-539. doi: 10.1164/rccm.202009-3431ED.
2
Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
J Infect Dis. 2020 Jun 16;222(1):4-6. doi: 10.1093/infdis/jiz409.
3
Respiratory syncytial virus: reverse genetics and vaccine strategies.
Virology. 2002 May 10;296(2):204-11. doi: 10.1006/viro.2002.1437.
4
Preparing for the future implementation of respiratory syncytial virus vaccines.
Lancet Respir Med. 2020 Mar;8(3):233-235. doi: 10.1016/S2213-2600(19)30478-3. Epub 2020 Jan 21.
5
Respiratory syncytial virus vaccines: an update on those in the immediate pipeline.
Future Microbiol. 2016 Oct;11:1479-1490. doi: 10.2217/fmb-2016-0106. Epub 2016 Oct 18.
6
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.
Clin Infect Dis. 2003 Dec 15;37(12):1668-77. doi: 10.1086/379775. Epub 2003 Nov 20.
7
Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
Expert Rev Vaccines. 2019 Oct;18(10):1053-1067. doi: 10.1080/14760584.2019.1675520. Epub 2019 Oct 14.
8
Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
J Infect Dis. 2018 Apr 11;217(9):1335-1337. doi: 10.1093/infdis/jiy038.
9
Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
Antiviral Res. 2019 Aug;168:9-17. doi: 10.1016/j.antiviral.2019.05.001. Epub 2019 May 7.
10
Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates.
Vaccine. 2003 Sep 8;21(25-26):3647-52. doi: 10.1016/s0264-410x(03)00426-2.
引用本文的文献
1
Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development.
Pathogens. 2025 Jan 21;14(2):104. doi: 10.3390/pathogens14020104.
2
Clinical research on RSV prevention in children and pregnant women: progress and perspectives.
Front Immunol. 2024 Jan 24;14:1329426. doi: 10.3389/fimmu.2023.1329426. eCollection 2023.
3
Respiratory syncytial virus infection and novel interventions.
Nat Rev Microbiol. 2023 Nov;21(11):734-749. doi: 10.1038/s41579-023-00919-w. Epub 2023 Jul 12.
4
Reclassification of respiratory syncytial virus genotypes in India.
Virusdisease. 2023 Mar;34(1):1-14. doi: 10.1007/s13337-022-00802-x. Epub 2022 Nov 27.
5
Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities.
Infect Dis Ther. 2023 Feb;12(2):317-332. doi: 10.1007/s40121-022-00737-2. Epub 2022 Dec 15.
6
Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.
Yale J Biol Med. 2022 Jun 30;95(2):293-300. eCollection 2022 Jun.
7
Update in Pediatrics 2020.
Am J Respir Crit Care Med. 2021 Aug 1;204(3):274-284. doi: 10.1164/rccm.202103-0605UP.
本文引用的文献
1
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.
Am J Respir Crit Care Med. 2021 Mar 1;203(5):594-603. doi: 10.1164/rccm.202005-1660OC.
2
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
J Infect Dis. 2021 Feb 24;223(4):699-708. doi: 10.1093/infdis/jiaa409.
3
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
N Engl J Med. 2020 Jul 30;383(5):426-439. doi: 10.1056/NEJMoa1908380.
4
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556.
5
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
Vaccine. 2020 Sep 3;38(39):6088-6095. doi: 10.1016/j.vaccine.2020.07.029. Epub 2020 Jul 25.
6
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children.
J Infect Dis. 2020 Jun 11;221(12):2050-2059. doi: 10.1093/infdis/jiaa049.
7
Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.
Lancet Public Health. 2017 Jul 31;2(8):e367-e374. doi: 10.1016/S2468-2667(17)30103-2. eCollection 2017 Aug.
8
Live attenuated versus inactivated influenza vaccine in infants and young children.
N Engl J Med. 2007 Feb 15;356(7):685-96. doi: 10.1056/NEJMoa065368.
Zotero 插件